Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents

Neuropsychopharmacology

Volumn 36, Issue 10, 2011, Pages 2062-2075

  Zhou, Yan ^a   Litvin, Yoav ^a   Piras, Anna Paola ^a   Pfaff, Donald W ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

arginine vasopressin; AVP EGFP mice; cocaine withdrawal; hypothalamic pituitary adrenal axis; SSR149415; V1b receptor

Indexed keywords

ARGIPRESSIN; COCAINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NALOXONE; NELIVAPTAN; OPIATE RECEPTOR; PROOPIOMELANOCORTIN; VASOPRESSIN V1B RECEPTOR;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; HORMONE BLOOD LEVEL; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MEDIAL PREOPTIC AREA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPRAOPTIC NUCLEUS;

ANIMALS; ARGININE VASOPRESSIN; COCAINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, TRANSGENIC; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PROMOTER REGIONS, GENETIC; RATS; RATS, INBRED F344; STRESS, PHYSIOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; UP-REGULATION;

EID: 80051782105     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.97     Document Type: Article

References (54)

1. Aguilera G (1994). Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15: 321-350.
2. Aguilera G, Rabadan-Diehl C (2000). Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96: 23-29.
3. Antoni FA (1993). Vasopressinergic control of pituitary adreno-corticotropin secretion comes of age. Front Neuroendocrinol 14: 76-122. (Pubitemid 23210952)
4. Aouizerate B, Ho A, Schluger J, Perret G, Borg L, Le Moal M et al (2006). Glucocorticoid negative feedback in methadone-main-tained former heroin addicts with cocaine dependence: dose-response to dexamethasone suppression. Addict Biol 11: 84-96. (Pubitemid 46696740)
5. Back SE, Hartwell K, Desantis SM, Saladin M, McRae-Clark AL, Price KL et al (2010). Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 106: 21-27.
6. Borowsky B, Kuhn CM (1991). Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res 543: 301-306.
7. Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE et al (2009). Response to cortico-tropin-releasing hormone infusion in cocaine dependent individuals. Arch Gen Psychiatry 66: 422-430.
8. Buydens-Branchey L, Branchey M, Hudson J, Majewska MD (2002). Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts. Psychoneur-oendocrinology 27: 83-97. (Pubitemid 34028159)
9. Contoreggi C, Herning RI, Koeppl B, Simpson PM, Negro Jr PJ, Fortner-Burton C et al (2003). Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion. Neuroendocrinology 78: 154-162. (Pubitemid 37188081)
10. Edwards S, Guerrero M, Ghoneim OM, Roberts E, Koob GF (2011). Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats. Addict Biol. (in press).
11. Elman I, Breiter HC, Gollub RL, Krause S, Kantor HL, Baumgartner WA et al (1999). Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence. Drug Alcohol Depend 56: 39-45. (Pubitemid 29295376)
12. Fox HC, Jackson ED, Sinha R (2009). Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes. Psychoneuroendocrinology 34: 1198-1207.
13. Gillies GE, Linton EA, Lowry PJ (1982). Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355-357. (Pubitemid 12012863)
14. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB et al (2003). A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425: 917-925. (Pubitemid 37376918)
15. Herman JP (1995). In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J Comp Neurol 363: 15-27.
16. Hernando F, Schoots O, Lolait SJ, Burbach JPH (2001). Immuno-histochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142: 1659-1668. (Pubitemid 32299697)
17. Jacobsen LK, Giedd JN, Kreek MJ, Gottschalk C, Kosten TR (2001). Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary- adrenal axis function in cocaine dependence: a preliminary report. Drug Alcohol Depend 62: 49-56. (Pubitemid 32149964)
18. Knepel W, Przewlocki R, Herz A (1985). Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypo-physectomized rats. Endocrinology 117: 292-299. (Pubitemid 15019818)
19. Koob GF (2008). A role for brain stress systems in addiction. Neuron 59: 11-34. (Pubitemid 351905857)
20. Koob GF, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149-1159. (Pubitemid 47292402)
21. Kosten TA, Ambrosio E (2002). HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27: 35-69. (Pubitemid 34028157)
22. Kovacs KJ, Sawchenko PE (1996). Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16: 262-273. (Pubitemid 26010715)
23. Kreek MJ, Zhou Y, Butelman ER, Levran O (2009). Opiate and cocaine addiction: from bench to clinic and back to bench. Curr Opin Pharmacol 9: 74-80.
24. Levy AQ, Li Q, Sanz MCA, Rittenhouse PA, Kerr JE, Van De Kar LD (1992). Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci 51: 887-897.
25. Lumley LA, Robison CL, Chen WK, Mark B, Meyerhoff JL (2001). Vasopressin into the preoptic area increases grooming behavior in mice. Physiol Behav 73: 451-455. (Pubitemid 32728444)
26. McEwen BS (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87: 873-904. (Pubitemid 47086281)
27. Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW (1998). Cocaine tolerance: behavioral, cardiovascular, and neuroendo-crine function in men. Neuropsychopharmacology 18: 263-271. (Pubitemid 28085525)
28. Moldow RL, Fischman AJ (1987). Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides 8: 819-822.
29. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmühl Y, Fischer D et al (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12: 1559-1566.
30. Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S (2002). Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Mol Brain Res 109: 84-94. (Pubitemid 36078376)
31. Nunez C, Földes A, Laorden ML, Milanes MV, Kovács KJ (2007). Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem 101: 1060-1071. (Pubitemid 46683869)
32. Peltier RL, Guerin GF, Dorairaj N, Goeders NE (2001). Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine. J Pharmacol Exp Ther 299: 114-120. (Pubitemid 32905125)
33. Picetti R, Ho A, Butelman ER, Kreek MJ (2010). Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats. Psychopharmacology (Berl) 211: 313-323.
34. Rhodes CH, Morrell JI, Pfaff DW (1981). Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol 198: 45-64. (Pubitemid 11090645)
35. Rivier C, Lee S (1994). Stimulatory effect of cocaine on ACTH section: role of the hypothalamus. Mol Cell Neurosci 5: 189-195. (Pubitemid 24118424)
36. Rivier C, Vale W (1983). Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113: 939-942. (Pubitemid 13051934)
37. Rodríguez-Borrero E, Rivera-Escalera F, Candelas F, Montalvo J, Muñoz-Miranda WJ, Walker JR et al (2010). Arginine vasopres-sin gene expression changes within the nucleus accumbens during environment elicited cocaine-conditioned response in rats. Neuropharmacology 58: 88-101.
38. Roper JA, O'Carroll A, Young III WS, Lolait SJ (2011). The vasopressin AVPr1b receptor: molecular and pharmacological studies. Stress 14: 98-115.
39. Sarnyai Z, Dhabhar FS, McEwen BS, Kreek MJ (1998). Neuroendo-crine- related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticoster-one response. Neuroendocrinology 68: 334-344. (Pubitemid 28526311)
40. Schluger JH, Borg L, Ho A, Kreek MJ (2001). Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuro-psychopharmacology 24: 568-575. (Pubitemid 32244317)
41. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G et al (2002). Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther 300: 1122-1130. (Pubitemid 34165020)
42. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ (2006). Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63: 324-331. (Pubitemid 43345357)
43. Vernotica EM, Rosenblatt JS, Morrell JI (1999). Microinfusion of cocaine into the medial preoptic area or nucleus accumbens transiently impairs maternal behavior in the rat. Behav Neurosci 113: 377-390. (Pubitemid 29230946)
44. Vescovi PP, Coiro V, Volpi R, Passeri M (1992). Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts. Horm Res 37: 221-224. (Pubitemid 23053664)
45. Viau V, Chu A, Soriano L, Dallman MF (1999). Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release. J Neurosci 19: 6684-6693. (Pubitemid 29347468)
46. Westberg L, Sawa E, Wang AY, Gunaydin LA, Ribeiro AC, Pfaff DW (2009). Colocalization of connexin 36 and CRH in the mouse brain. BMC Neurosci 10: 41.
47. Wigger A, Sánchez MM, Mathys KC, Ebner K, Frank E, Liu D et al (2004). Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 29: 1-14. (Pubitemid 38068008)
48. Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D et al (2005). DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuro-endocrinology 30: 18-28. (Pubitemid 39195041)
49. Zhou Y, Bendor J, Yuferov V, Schlussman SD, Ho A, Kreek MJ (2005). Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation. Neuroscience 134: 1391-1397. (Pubitemid 41207386)
50. Zhou Y, Cui CL, Schlussman SD, Choi J, Ho A, Han JS et al (2008a). Effect of cocaine place conditioning, chronic escalating-dose binge pattern cocaine and its acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in the lateral hypothalamus. Neuroscience 153: 1225-1234.
51. Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ (2008b). Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33: 226-236. (Pubitemid 350243360)
52. Zhou Y, Spangler R, Ho A, Kreek MJ (2003). Increased CRH mRNA levels in the rat amygdala during acute withdrawal from chronic "binge" cocaine. Mol Brain Res 114: 73-79. (Pubitemid 36627998)
53. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ (1996). Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during 'binge'-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279: 351-358.
54. Zorrilla EP, Valdez GR, Weiss F 2001. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharma-cology 158: 374-381. (Pubitemid 33141313)